Zhe B. Wu
12# Wulumuqi Middle Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Chinese consensus on the diagnosis and treatment of prolactinomas (2025 edition).
Journal: Chinese neurosurgical journal
Published: February 28, 2026
A MYCN-GAL-SREBP1 Lipogenic Axis Drives Proliferation in Silent Corticotroph Adenomas.
Journal: Neuro-oncology
Published: January 26, 2026
Immune and clinicopathological features of molecularly defined prolactinoma subtypes.
Journal: Journal of neurosurgery
Published: July 10, 2025
Initial Clinical Experience Using Naked-Eye 3D 4K Exoscope for Vestibular Schwannoma.
Journal: The Journal of craniofacial surgery
Published: July 03, 2025
Advances in Drug Treatments for Male Patients with Prolactinomas.
Journal: Neuroendocrinology
Published: March 08, 2025
Targeting FSHR is a highly promising strategy for improving cognitive impairment in postmenopausal women.
Journal: Molecular psychiatry
Published: December 30, 2024
TRIM21-mediated ubiquitination and phosphorylation of ERK1/2 promotes cell proliferation and drug resistance in pituitary adenomas.
Journal: Neuro-oncology
Published: November 13, 2024
CAD-CAM of elastic plugs with multilayer porous channels following 3D construction of jaw cyst-mucosa-dentition after decompression: A dental technique.
Journal: The Journal of prosthetic dentistry
Published: September 27, 2024
Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axis.
Journal: Neuro-oncology
Published: July 11, 2024
Disulfiram mediated anti-tumour effect in pituitary neuroendocrine tumours by inducing cuproptosis.
Journal: International immunopharmacology
Published: January 24, 2024
Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas.
Journal: Cancers
Published: January 04, 2024
Last Updated: 09/26/2026